Interleukin-1β-Treated Mesenchymal Stem Cells Inhibit Inflammation in Hippocampal Astrocytes Through Exosome-Activated Nrf-2 Signaling-Reference-Cited by-同舟云学术

Interleukin-1β-Treated Mesenchymal Stem Cells Inhibit Inflammation in Hippocampal Astrocytes Through Exosome-Activated Nrf-2 Signaling

Published:2021-02 Issue: Volume:Volume 16 Page:1423-1434
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Liu Kai,Cai Guo-Liang,Zhuang Zhe,Pei Si-Ying,Xu Sheng-Nan,Wang Ya-Nan,Wang Hong,Wang Xin,Cui Cheng,Sun Man-Chao,Guo Si-Hui,Jia Kun-Ping,Wang Xiu-Zhen,Cai Guo-Feng

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Reference51 articles.

1. The role of inflammation in CNS injury and disease

2. Cytokine-induced sickness behaviour: mechanisms and implications

3. Inflammation, microglia, and alzheimer's disease

4. Interleukin 1 in the brain: biology, pathology and therapeutic target

5. Multilineage Potential of Adult Human Mesenchymal Stem Cells

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of the Nrf2/HO-1 axis by mesenchymal stem cells-derived extracellular vesicles: implications for disease treatment;Frontiers in Cell and Developmental Biology;2024-06-10

2. Three-dimensional dynamic culture and hypoxic preconditioning synergistically enhance the therapeutic effects of GMSCs on intracerebral hemorrhage;Materials Today Nano;2024-06

3. Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy;Ibrain;2024-05-29

4. Selenomethionine preconditioned mesenchymal stem cells derived extracellular vesicles exert enhanced therapeutic efficacy in intervertebral disc degeneration;International Immunopharmacology;2024-05

5. Exosomes as a therapeutic tool to promote neurorestoration and cognitive function in neurological conditions: Achieve two ends with a single effort;CNS Neuroscience & Therapeutics;2024-05